Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GRTX - Is Galera Therapeutics Stock A Buy Sell Or Hold? Several Catalysts To Watch In 2022

GRTX - Is Galera Therapeutics Stock A Buy Sell Or Hold? Several Catalysts To Watch In 2022

Galera Therapeutics Inc.
  • Galera Therapeutics is developing drugs that reduce side effects from anti-cancer radiotherapy and improve the treatment outcome.
  • Clinical trial data have demonstrated statistically significant efficacy for the Avasopasem drug against severe oral mucositis.
  • A pending meeting with the FDA this year could open the door for a new drug application.
  • The stock looks interesting on the selloff.

For further details see:

Is Galera Therapeutics Stock A Buy, Sell, Or Hold? Several Catalysts To Watch In 2022
Stock Information
Company Name: Galera Therapeutics Inc.
Stock Symbol: GRTX
Market: NYSE
Website: galeratx.com
Menu
GRTX GRTX Quote GRTX Short GRTX News GRTX Articles GRTX Message Board
Get GRTX Alerts

News, Short Squeeze, Breakout and More Instantly...